SCHEMBL2525288

SCHEMBL2525288

Fc1ccc(-c2cc(CCOCc3ccccc3)[nH]n2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 1/20 0.45
LMNA P02545 1/20 0.43
CA12 O43570 1/20 0.43
ALPL P05186 1/20 0.43
RPA1 P27694 1/20 0.43
MAPT P10636 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
NPC1 O15118 1/20 0.42
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40
NR1H4 Q96RI1 1/20 0.40
PDE10A Q9Y233 1/20 0.39
HRH4 Q9H3N8 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
COMT P21964 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PRCP P42785 1/20 0.38
RET P07949 1/20 0.38
KDR P35968 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2824086 0.83 COMT (0.53) LMNACA12ALPLRPA1MAPT
SCHEMBL16637217 0.76 TSHR (0.46) MEN1KMT2AHRH4HRH3COMT
SCHEMBL28013856 0.74 MAPT (0.48) CA12ALPLRPA1MAPTMEN1
SCHEMBL27922929 0.74 COMT (0.58) LMNAMAPTCYP11B1CYP11B2NR1H4
SCHEMBL2375007 0.73 L3MBTL1 (0.54) LMNAMAPTMEN1KMT2ANPC1
SCHEMBL28172289 0.72 MAPT (0.63) LMNACA12ALPLRPA1MAPT
SCHEMBL14985499 0.72 HCAR2 (0.51) CA12ALPLRPA1MAPTMEN1
SCHEMBL2522578 0.72 CA12 (0.53) LMNACA12ALPLRPA1MAPT
SCHEMBL14814428 0.70 CA12 (0.54) LMNACA12ALPLRPA1MAPT
SCHEMBL14985512 0.70 CA12 (0.50) LMNACA12ALPLRPA1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102947303-B Bicyclo-pyridyl pyrazoles BAYER INTELLECTUAL PROPERTY GMBH (DE) 2016-12-14 CN disclosed
EP-2556073-B1 BICYCLIC PYRIDINYL PYRAZOLES BAYER IP GMBH (DE) 2014-07-23 EP disclosed
US-8507472-B2 Bicyclic pyridinylpyrazoles BAYER CROPSCIENCE AG (DE) 2013-08-13 US disclosed
EP-2556073-A1 BICYCLIC PYRIMIDINYL PYRAZOLES Bayer Intellectual Property GmbH (DE) 2013-02-13 EP disclosed
WO-2011124539-A1 BICYCLIC PYRIMIDINYL PYRAZOLES BAYER CROPSCIENCE AG (DE) 2011-10-13 WO disclosed
US-20110251178-A1 Bicyclic Pyridinylpyrazoles BAYER CROPSCIENCE AG (DE) 2011-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110251178-A1 Bicyclic Pyridinylpyrazoles PLPBP, PNPO, PIR DHODH 2307/4885LMNA 547/4885CA12 4324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.